| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Oncology and Molecular Endocrinology Research Center, Medical Research Council Group in Molecular Endocrinology (A.B.), CHUL Research Center, Laval University, Quebec, Canada G1V 4G2
Address all correspondence and requests for reprints to: Dr. Alain Bélanger, Oncology and Molecular Endocrinology Research Center, CHUL Research Center, 2705 Laurier Boulevard, Quebec, Canada G1V 4G2. E-mail: alain.belanger{at}crchul.ulaval.ca
UDP-glucuronosyltransferase (UGT) enzymes catalyze the transfer of the
glucuronide group from UDP-glucuronic acid to several exogenous or
endogenous compounds, including steroid hormones. Although it is widely
recognized that the liver is a major site of steroid glucuronidation,
RT-PCR analysis has shown the expression of UGT2B transcripts in
extrahepatic steroid target tissues such as the prostate. Measurement
of androgen metabolites in human prostate revealed high levels of
C19 steroid glucuronides such as androsterone glucuronide
and 3
-diol glucuronide, thus suggesting an important role of UGT2B
enzymes in androgen metabolism. To investigate the cellular
localization of UGT2B expression in the human prostate, the present
in situ hybridization studies demonstrated the presence
of UGT2B transcripts in epithelial cells lining the acinii. All basal
cells were intensively labeled, whereas the luminal secretory cells
were moderately labeled. To confirm these results, an
immunohistological analysis was performed using a specific anti-UGT2B
antibody. The presence of UGT2B proteins was observed in both basal and
luminal cells of prostate epithelium, in fibrocytes of stroma and blood
vessels, and in endothelial cells of blood vessels. Using a specific
anti-UGT2B17 antibody, the expression of this androsterone-conjugating
UGT enzyme was found exclusively in basal cells of the epithelium.
These results demonstrate the expression of androgen-conjugating UGT2B
enzymes in human prostatic epithelium. Moreover, they show for the
first time a cell type-specific expression of an UGT2B isoform.
This article has been cited by other articles:
![]() |
J. Azzarello, K.-M. Fung, and H.-K. Lin Tissue Distribution of Human AKR1C3 and Rat Homolog in the Adult Genitourinary System J. Histochem. Cytochem., September 1, 2008; 56(9): 853 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chouinard, O. Barbier, and A. Belanger UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 Enzymes Are Major Determinants of the Androgen Response in Prostate Cancer LNCaP Cells J. Biol. Chem., November 16, 2007; 282(46): 33466 - 33474. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gaganis, J. O. Miners, J. S. Brennan, A. Thomas, and K. M. Knights Human Renal Cortical and Medullary UDP-Glucuronosyltransferases (UGTs): Immunohistochemical Localization of UGT2B7 and UGT1A Enzymes and Kinetic Characterization of S-Naproxen Glucuronidation J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 422 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chouinard, G. Pelletier, A. Belanger, and O. Barbier Isoform-Specific Regulation of Uridine Diphosphate-Glucuronosyltransferase 2B Enzymes in the Human Prostate: Differential Consequences for Androgen and Bioactive Lipid Inactivation Endocrinology, November 1, 2006; 147(11): 5431 - 5442. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Obligacion, M. Murray, and I. Ramzan Drug-Metabolizing Enzymes and Transporters: Expression in the Human Prostate and Roles in Prostate Drug Disposition J Androl, March 1, 2006; 27(2): 138 - 150. [Full Text] [PDF] |
||||
![]() |
J. Jakobsson, L. Ekstrom, N. Inotsume, M. Garle, M. Lorentzon, C. Ohlsson, H.-K. Roh, K. Carlstrom, and A. Rane Large Differences in Testosterone Excretion in Korean and Swedish Men Are Strongly Associated with a UDP-Glucuronosyl Transferase 2B17 Polymorphism J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 687 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lepine, O. Bernard, M. Plante, B. Tetu, G. Pelletier, F. Labrie, A. Belanger, and C. Guillemette Specificity and Regioselectivity of the Conjugation of Estradiol, Estrone, and Their Catecholestrogen and Methoxyestrogen Metabolites by Human Uridine Diphospho-glucuronosyltransferases Expressed in Endometrium J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5222 - 5232. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Rizner, H. K. Lin, D. M. Peehl, S. Steckelbroeck, D. R. Bauman, and T. M. Penning Human Type 3 3{alpha}-Hydroxysteroid Dehydrogenase (Aldo-Keto Reductase 1C2) and Androgen Metabolism in Prostate Cells Endocrinology, July 1, 2003; 144(7): 2922 - 2932. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Girard, O. Barbier, G. Veilleux, M. El-Alfy, and A. Belanger Human Uridine Diphosphate-Glucuronosyltransferase UGT2B7 Conjugates Mineralocorticoid and Glucocorticoid Metabolites Endocrinology, June 1, 2003; 144(6): 2659 - 2668. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Turgeon, S. Chouinard, P. Belanger, S. Picard, J.-F. Labbe, P. Borgeat, and A. Belanger Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases J. Lipid Res., June 1, 2003; 44(6): 1182 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Gestl, M. D. Green, D. A. Shearer, E. Frauenhoffer, T. R. Tephly, and J. Weisz Expression of UGT2B7, a UDP-Glucuronosyltransferase Implicated in the Metabolism of 4-Hydroxyestrone and All-Trans Retinoic Acid, in Normal Human Breast Parenchyma and in Invasive and in Situ Breast Cancers Am. J. Pathol., April 1, 2002; 160(4): 1467 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Congiu, M. L. Mashford, J. L. Slavin, and P. V. Desmond UDP Glucuronosyltransferase mRNA Levels in Human Liver Disease Drug Metab. Dispos., February 1, 2002; 30(2): 129 - 134. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |